1. Home
  2. ALVOW vs MGIC Comparison

ALVOW vs MGIC Comparison

Compare ALVOW & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVOW
  • MGIC
  • Stock Information
  • Founded
  • ALVOW 2013
  • MGIC 1983
  • Country
  • ALVOW Luxembourg
  • MGIC Israel
  • Employees
  • ALVOW 999
  • MGIC N/A
  • Industry
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • ALVOW Health Care
  • MGIC Technology
  • Exchange
  • ALVOW Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • ALVOW N/A
  • MGIC N/A
  • IPO Year
  • ALVOW N/A
  • MGIC 1991
  • Fundamental
  • Price
  • ALVOW $1.83
  • MGIC $13.88
  • Analyst Decision
  • ALVOW
  • MGIC Buy
  • Analyst Count
  • ALVOW 0
  • MGIC 2
  • Target Price
  • ALVOW N/A
  • MGIC $16.00
  • AVG Volume (30 Days)
  • ALVOW 15.0K
  • MGIC 100.6K
  • Earning Date
  • ALVOW 02-27-2025
  • MGIC 03-11-2025
  • Dividend Yield
  • ALVOW N/A
  • MGIC 3.18%
  • EPS Growth
  • ALVOW N/A
  • MGIC N/A
  • EPS
  • ALVOW N/A
  • MGIC 0.75
  • Revenue
  • ALVOW $393,919,000.00
  • MGIC $552,520,000.00
  • Revenue This Year
  • ALVOW N/A
  • MGIC $4.41
  • Revenue Next Year
  • ALVOW N/A
  • MGIC $4.91
  • P/E Ratio
  • ALVOW N/A
  • MGIC $18.29
  • Revenue Growth
  • ALVOW 517.92
  • MGIC N/A
  • 52 Week Low
  • ALVOW $2.33
  • MGIC $9.51
  • 52 Week High
  • ALVOW $2.33
  • MGIC $14.04
  • Technical
  • Relative Strength Index (RSI)
  • ALVOW N/A
  • MGIC 65.15
  • Support Level
  • ALVOW N/A
  • MGIC $13.39
  • Resistance Level
  • ALVOW N/A
  • MGIC $14.04
  • Average True Range (ATR)
  • ALVOW 0.00
  • MGIC 0.40
  • MACD
  • ALVOW 0.00
  • MGIC 0.18
  • Stochastic Oscillator
  • ALVOW 0.00
  • MGIC 93.31

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: